80 results
S-8
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Registration of securities for employees
4:47pm
, including any amendment or report filed for the purpose of updating such description.
All documents filed by the Registrant pursuant to Sections 13 … ) that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
S-8
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Registration of securities for employees
4:47pm
) of Rule 457 under the Securities Act solely for the purpose of calculating the registration fee on the basis of 13.58 per share, which represents … for the purpose of calculating the registration fee on the basis of 85% of 13.58 per share, which represents the average of the high and low price per
8-K
EX-10.1
ujip3bzepw
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
S-3ASR
EX-4.2
5px20rss69ssi
11 Mar 24
Automatic shelf registration
5:28pm
S-3ASR
55z8aybikjro9he2
11 Mar 24
Automatic shelf registration
5:28pm
8-K
EX-10.1
12hlnatbglwa26ae6
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
S-3
6wt 8c4woaqrbmjhb3z
15 Dec 23
Shelf registration
4:32pm
S-3
3cksthaqsvdss7op6g
15 Dec 23
Shelf registration
4:32pm
8-K
EX-10.1
cpqwk
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-4.1
rfgfhuh
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am